Certain important genes (KRAS, TP53, CDKN2A, and SMAD4) have been shown to be the most frequently mutated in PDA and to characterize various steps in carcinogenesis (Vincent et al., 2011). This evidence concerns the gene KRAS and Patent ductus arteriosus.